Bellecapital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-120
| Closed | -$12.8K | – | 166 |
|
2024
Q2 | $12.8K | Sell |
120
-797
| -87% | -$84.8K | ﹤0.01% | 149 |
|
2024
Q1 | $1.47M | Hold |
917
| – | – | 0.32% | 52 |
|
2023
Q4 | $1.61M | Buy |
+917
| New | +$1.61M | 0.36% | 49 |
|
2022
Q3 | – | Sell |
-5,387
| Closed | -$455K | – | 202 |
|
2022
Q2 | $455K | Hold |
5,387
| – | – | 0.13% | 120 |
|
2022
Q1 | $473K | Sell |
5,387
-87
| -2% | -$7.64K | 0.15% | 117 |
|
2021
Q4 | $479K | Sell |
5,474
-87
| -2% | -$7.61K | 0.14% | 121 |
|
2021
Q3 | $455K | Hold |
5,561
| – | – | 0.14% | 125 |
|
2021
Q2 | $507K | Hold |
5,561
| – | – | 0.15% | 120 |
|
2021
Q1 | $475K | Sell |
5,561
-148
| -3% | -$12.6K | 0.15% | 113 |
|
2020
Q4 | $539K | Buy |
5,709
+302
| +6% | +$28.5K | 0.18% | 98 |
|
2020
Q3 | $470K | Buy |
5,407
+797
| +17% | +$69.3K | 0.22% | 87 |
|
2020
Q2 | $403K | Hold |
4,610
| – | – | 0.19% | 86 |
|
2020
Q1 | $380K | Hold |
4,610
| – | – | 0.24% | 83 |
|
2019
Q4 | $437K | Hold |
4,610
| – | – | 0.22% | 90 |
|
2019
Q3 | $401K | Hold |
4,610
| – | – | 0.24% | 84 |
|
2019
Q2 | $421K | Sell |
4,610
-535
| -10% | -$48.9K | 0.26% | 79 |
|
2019
Q1 | $390K | Buy |
5,145
+134
| +3% | +$10.2K | 0.25% | 76 |
|
2018
Q4 | $385K | Buy |
5,011
+256
| +5% | +$19.7K | 0.27% | 64 |
|
2018
Q3 | $367K | Buy |
4,755
+409
| +9% | +$31.6K | 0.24% | 64 |
|
2018
Q2 | $294K | Hold |
4,346
| – | – | 0.21% | 68 |
|
2018
Q1 | $315K | Buy |
4,346
+122
| +3% | +$8.84K | 0.29% | 63 |
|
2017
Q4 | $318K | Hold |
4,224
| – | – | 0.26% | 60 |
|
2017
Q3 | $325K | Hold |
4,224
| – | – | 0.38% | 51 |
|
2017
Q2 | $316K | Hold |
4,224
| – | – | 0.28% | 51 |
|
2017
Q1 | $281K | Buy |
+4,224
| New | +$281K | 0.26% | 58 |
|